-
10 Jim Cramer Sell Ideas Gone Wrong
Thursday, April 21, 2011 - 3:38pm | 121Investment Underground anticipates two scenarios for Q2 2011. Investors will head for the exits amid choppy markets, congressional debt grappling and QE2 curtailment, or investors will scoop up bargains paying dividends, often paying yields in excess of company bonds. Either way, these names should...
-
Consider Shorting These 6 Stocks
Thursday, April 21, 2011 - 3:36pm | 121Investment Underground anticipates two scenarios for Q2 2011. Investors will head for the exits amid choppy markets, congressional debt grappling and QE2 curtailment, or investors will scoop up bargains paying dividends, often paying yields in excess of company bonds. Either way, these names should...
-
4 Tech Stocks Buffett Might Buy This Year
Thursday, April 21, 2011 - 3:31pm | 121Investment Underground anticipates two scenarios for Q2 2011. Investors will head for the exits amid choppy markets, congressional debt grappling and QE2 curtailment, or investors will scoop up bargains paying dividends, often paying yields in excess of company bonds. Either way, these names should...
-
Why Is George Soros Selling AT&T and Verizon?
Thursday, April 21, 2011 - 3:27pm | 121Investment Underground anticipates two scenarios for Q2 2011. Investors will head for the exits amid choppy markets, congressional debt grappling and QE2 curtailment, or investors will scoop up bargains paying dividends, often paying yields in excess of company bonds. Either way, these names should...
-
Guru Investing: Thoughts on John Paulson's 17 Favorite Holdings (Part II)
Thursday, April 21, 2011 - 3:24pm | 121Investment Underground anticipates two scenarios for Q2 2011. Investors will head for the exits amid choppy markets, congressional debt grappling and QE2 curtailment, or investors will scoop up bargains paying dividends, often paying yields in excess of company bonds. Either way, these names should...
-
Guru Investing: Thoughts on John Paulson's 17 Favorite Holdings (Part I)
Thursday, April 21, 2011 - 3:21pm | 121Investment Underground anticipates two scenarios for Q2 2011. Investors will head for the exits amid choppy markets, congressional debt grappling and QE2 curtailment, or investors will scoop up bargains paying dividends, often paying yields in excess of company bonds. Either way, these names should...
-
Spectrum Pharma Resumes Trading (SPPI)
Thursday, April 21, 2011 - 3:10pm | 14Spectrum Pharma (NASDAQ: SPPI) Resumes Trading.
-
PREVIEW: Spectrum Pharma To Resume Trading at 3:10pm, Released FDA Approval (SPPI)
Thursday, April 21, 2011 - 2:53pm | 50Spectrum Pharmaceuticals (NASDAQ: SPPI) today announced that the U.S. Food and Drug Administration has approved the Company's Supplemental New Drug Application for FUSILEV Injection. Unlike the currently available lyophilized product, this approval is for a “Ready-to-Use” formulation of FUSILEV for...
-
Spectrum Pharmaceuticals Announces FDA Approval of FUSILEV's Ready-to-Use Formulation
Thursday, April 21, 2011 - 2:42pm | 50Spectrum Pharmaceuticals (Nasdaq: SPPI) today announced that the U.S. Food and Drug Administration has approved the Company's Supplemental New Drug Application for FUSILEV Injection. Unlike the currently available lyophilized product, this approval is for a “Ready-to-Use” formulation of FUSILEV for...
-
22 Lottery Stocks Under $10
Thursday, April 21, 2011 - 2:34pm | 257Unlike any of my other screens, this stock screen focuses on stocks trading under $10/share, and have a market cap of around $1 billion or less. As for the variables that I used in the screen, I focused on fundamentals, particularly companies that have a healthy balance sheet with little debt...
-
Trading Halted: Spectrum Pharmaceuticals, News Pending (SPPI)
Thursday, April 21, 2011 - 2:30pm | 16Trading Halted: Spectrum Pharmaceuticals (NASDAQ: SPPI), News Pending
-
Under The Hood: A Value Proposition
Thursday, April 21, 2011 - 2:27pm | 510There is always going to be some debate in the world of investing between value and growth. Some argue that value stocks outperform growth stocks, but naysayers will question the time periods in which it takes for value plays to outshine growth stars. Years? Decades? Longer? Obviously, growth...
-
Four Deaths Reported In Study Of Experimental Pfizer Arthritis Drug - DJ (PFE, ABT)
Thursday, April 21, 2011 - 2:19pm | 34Four Deaths Reported In Study Of Experimental Pfizer (NYSE: PFE) Arthritis Drug, Reported By Dow Jones (NYSE: ABT)
-
Pfizer Plunges Intra-Day (PFE)
Thursday, April 21, 2011 - 1:58pm | 77Shares of Pfizer Inc. (NYSE: PFE), the blue-chip pharmaceutical company, have plunged intra-day on thursday. Currently the stock is trading down 4%. There does not appear to be any news out that would account for the swift price drop in the stock. This is a huge move for Pfizer, and it looks like...
-
Abbott Laboratories Spiking (ABT)
Thursday, April 21, 2011 - 1:53pm | 25Abbott Laboratories (NYSE: ABT) just started spiking. At last check, shares were up $1.10 to $51.90, a gain of 2.2%.